30 Mar 2014 Posted in News Release By Press Office
“The ABPI welcomes today’s announcement by Earl Howe of the Government’s plan to fund a centralised Health Research Authority assessment and approval process for research in the NHS in England. The ABPI has previously called for a streamlined research governance process to help improve UK competitiveness and the new process will greatly facilitate the process of setting up of research studies.
“Improved NHS management of clinical trials is a key driver of UK competitiveness ensuring that clinical research remains at the heart of innovation in the NHS”.
Tel: +44 (0) 20 7747 1410 or +44 (0) 20 7747 1441
Mobile: +44 (0) 7850 312064 or +44 (0) 7808 641811 Email: firstname.lastname@example.org
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Our members supply 90 per cent of all medicines used by the NHS, and are researching and developing over two-thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
The ABPI is recognised by Government as the industry body negotiating on behalf of the branded pharmaceutical industry, for statutory consultation requirements including the pricing scheme for medicines in the UK.